Il y a eu 50 transactions d'initiés récentes enregistrées pour Kura Oncology, Inc. (KURA), dont 30 achats et 20 ventes. Le total des achats d'initiés s'élève à $20.15M et le total des ventes d'initiés à $1.57M.
Les initiés notables ayant une activité récente comprennent Wilson Troy Edward, Malley Thomas, Ford Kathleen. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — KURA
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-23 |
Wilson Troy Edward |
President and CEO |
Exercice d'Options |
6,103 |
$6.15 |
$37.53K |
- |
| 2026-03-18 |
Malley Thomas |
Director |
Exercice d'Options |
10,000 |
$3.12 |
$31.2K |
- |
| 2026-01-27 |
Ford Kathleen |
Chief Operating Officer |
Vente Informative |
1,813 |
$8.46 |
$15.34K |
153,560 |
| 2026-01-27 |
Bair Teresa Brophy |
Chief Legal Officer |
Vente Informative |
4,777 |
$8.46 |
$40.42K |
226,931 |
| 2026-01-27 |
Doyle Thomas James |
SVP, Finance & Accounting |
Vente Informative |
881 |
$8.46 |
$7.45K |
145,167 |
| 2026-01-27 |
Powl Brian T. |
Chief Commercial Officer |
Vente Informative |
1,572 |
$8.46 |
$13.3K |
183,275 |
| 2026-01-27 |
Leoni Mollie |
Chief Medical Officer |
Vente Informative |
1,341 |
$8.46 |
$11.35K |
267,274 |
| 2026-01-27 |
Burrows Francis |
Chief Scientific Officer |
Vente Informative |
1,311 |
$8.46 |
$11.09K |
32,424 |
| 2026-01-02 |
Wilson Troy Edward |
President and CEO |
Attribution de RSU |
1,120,000 |
$10.34 |
$11.58M |
1,120,000 |
| 2026-01-02 |
Ford Kathleen |
Chief Operating Officer |
Attribution de RSU |
100,000 |
$10.34 |
$1.03M |
100,000 |
| 2026-01-02 |
Bair Teresa Brophy |
Chief Legal Officer |
Attribution de RSU |
100,000 |
$10.34 |
$1.03M |
100,000 |
| 2026-01-02 |
Doyle Thomas James |
SVP, Finance & Accounting |
Attribution de RSU |
42,500 |
$10.34 |
$439.24K |
42,500 |
| 2026-01-02 |
Powl Brian T. |
Chief Commercial Officer |
Attribution de RSU |
100,000 |
$10.34 |
$1.03M |
100,000 |
| 2026-01-02 |
Leoni Mollie |
Chief Medical Officer |
Attribution de RSU |
100,000 |
$10.34 |
$1.03M |
100,000 |
| 2026-01-02 |
Burrows Francis |
Chief Scientific Officer |
Attribution de RSU |
185,000 |
$10.34 |
$1.91M |
185,000 |
| 2025-12-18 |
Burrows Francis |
Chief Scientific Officer |
Exercice d'Options (Vente) |
35,000 |
$4.80 |
$168K |
- |
| 2025-12-09 |
Hasnain Faheem |
Director |
Vente Informative |
10,000 |
$10.98 |
$109.76K |
23,983 |
| 2025-11-14 |
Ford Kathleen |
Chief Operating Officer |
Vente Informative |
6,902 |
$11.18 |
$77.14K |
105,373 |
| 2025-11-14 |
Bair Teresa Brophy |
Chief Legal Officer |
Vente Informative |
8,804 |
$11.18 |
$98.4K |
188,139 |
| 2025-11-14 |
Doyle Thomas James |
SVP, Finance & Accounting |
Vente Informative |
4,539 |
$11.18 |
$50.73K |
130,257 |
| 2025-11-14 |
Powl Brian T. |
Chief Commercial Officer |
Vente Informative |
8,887 |
$11.18 |
$99.33K |
139,689 |
| 2025-11-14 |
Leoni Mollie |
Chief Medical Officer |
Vente Informative |
15,485 |
$11.18 |
$173.07K |
225,454 |
| 2025-11-13 |
Wilson Troy Edward |
President and CEO |
Attribution de RSU |
182,500 |
- |
- |
429,353 |
| 2025-11-13 |
Ford Kathleen |
Chief Operating Officer |
Attribution de RSU |
48,900 |
- |
- |
112,275 |
| 2025-11-13 |
Bair Teresa Brophy |
Chief Legal Officer |
Attribution de RSU |
48,900 |
- |
- |
196,943 |
| 2025-11-13 |
Doyle Thomas James |
SVP, Finance & Accounting |
Attribution de RSU |
24,967 |
- |
- |
134,796 |
| 2025-11-13 |
Powl Brian T. |
Chief Commercial Officer |
Attribution de RSU |
48,900 |
- |
- |
148,576 |
| 2025-11-13 |
Leoni Mollie |
Chief Medical Officer |
Attribution de RSU |
82,500 |
- |
- |
240,939 |
| 2025-09-29 |
Wilson Troy Edward |
President and CEO |
Vente Informative |
36,615 |
$8.94 |
$327.42K |
246,853 |
| 2025-09-29 |
Ford Kathleen |
Chief Operating Officer |
Vente Informative |
6,892 |
$8.94 |
$61.63K |
63,375 |
| 2025-09-29 |
Bair Teresa Brophy |
Chief Legal Officer |
Vente Informative |
8,805 |
$8.94 |
$78.74K |
148,043 |
| 2025-09-29 |
Doyle Thomas James |
SVP, Finance & Accounting |
Vente Informative |
4,541 |
$8.94 |
$40.61K |
109,829 |
| 2025-09-29 |
Powl Brian T. |
Chief Commercial Officer |
Vente Informative |
8,891 |
$8.94 |
$79.51K |
99,676 |
| 2025-09-29 |
Leoni Mollie |
Chief Medical Officer |
Vente Informative |
12,314 |
$8.94 |
$110.11K |
158,439 |
| 2025-09-27 |
Wilson Troy Edward |
President and CEO |
Attribution de RSU |
182,500 |
- |
- |
283,468 |
| 2025-09-27 |
Ford Kathleen |
Chief Operating Officer |
Retour de RSU |
48,900 |
- |
- |
70,267 |
| 2025-09-27 |
Bair Teresa Brophy |
Chief Legal Officer |
Attribution de RSU |
48,900 |
- |
- |
156,848 |
| 2025-09-27 |
Doyle Thomas James |
SVP, Finance & Accounting |
Attribution de RSU |
24,966 |
- |
- |
114,370 |
| 2025-09-27 |
Powl Brian T. |
Chief Commercial Officer |
Attribution de RSU |
48,900 |
- |
- |
108,567 |
| 2025-09-27 |
Leoni Mollie |
Chief Medical Officer |
Attribution de RSU |
82,500 |
- |
- |
170,753 |
| 2025-09-08 |
Wilson Troy Edward |
President & CEO |
Achat Informatif |
50,000 |
$8.20 |
$410.15K |
100,968 |
| 2025-08-13 |
Wilson Troy Edward |
President and CEO |
Achat Informatif |
13,494 |
$6.64 |
$89.62K |
50,968 |
| 2025-08-12 |
Wilson Troy Edward |
President and CEO |
Achat Informatif |
36,506 |
$5.85 |
$213.58K |
37,474 |
| 2025-06-05 |
Schafer Carol |
Director |
Attribution de RSU |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Hasnain Faheem |
Director |
Attribution de RSU |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Malley Thomas |
Director |
Attribution de RSU |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Szela Mary T |
Director |
Attribution de RSU |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Collins Helen Louise |
Director |
Attribution de RSU |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Vasconcelles Michael |
Director |
Attribution de RSU |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Parks Diane L. |
Director |
Attribution de RSU |
28,500 |
$6.57 |
$187.25K |
28,500 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
